Walleye Trading’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.39M Sell
22,200
-183,900
-89% -$28.2M 0.01% 1375
2025
Q4
$28.4M Sell
206,100
-22,300
-10% -$2.92M 0.04% 470
2025
Q3
$29.3M Buy
228,400
+145,700
+176% +$17.8M 0.04% 438
2025
Q2
$10M Buy
82,700
+38,600
+88% +$4.35M 0.02% 815
2025
Q1
$4.92M Sell
44,100
-71,100
-62% -$7.57M 0.01% 1103
2024
Q4
$11.2M Sell
115,200
-46,100
-29% -$4.92M 0.02% 731
2024
Q3
$18.6M Buy
161,300
+16,900
+12% +$1.92M 0.04% 497
2024
Q2
$15.4M Buy
144,400
+32,400
+29% +$3.25M 0.04% 500
2024
Q1
$10.8M Sell
112,000
-219,700
-66% -$22.5M 0.02% 674
2023
Q4
$33.5M Buy
331,700
+73,700
+29% +$7.11M 0.07% 266
2023
Q3
$26.3M Buy
258,000
+85,200
+49% +$8.65M 0.07% 283
2023
Q2
$17.4M Buy
172,800
+111,100
+180% +$11.1M 0.05% 342
2023
Q1
$5.68M Sell
61,700
-55,500
-47% -$4.85M 0.01% 949
2022
Q4
$10.6M Buy
117,200
+7,500
+7% +$632K 0.03% 631
2022
Q3
$8.34M Buy
109,700
+10,100
+10% +$837K 0.03% 714
2022
Q2
$8.42M Buy
99,600
+90,000
+938% +$7.9M 0.03% 725
2022
Q1
$842K Sell
9,600
-103,100
-91% -$8.93M ﹤0.01% 2391
2021
Q4
$9.86M Buy
112,700
+96,200
+583% +$7.99M 0.03% 612
2021
Q3
$1.35M Buy
16,500
+7,500
+83% +$675K ﹤0.01% 1928
2021
Q2
$821K Sell
9,000
-1,600
-15% -$142K ﹤0.01% 2344
2021
Q1
$906K Sell
10,600
-25,900
-71% -$2.32M ﹤0.01% 2006
2020
Q4
$3.45M Buy
36,500
+26,600
+269% +$2.32M 0.02% 974
2020
Q3
$861K Buy
9,900
+6,100
+161% +$528K ﹤0.01% 1778
2020
Q2
$332K Sell
3,800
-11,800
-76% -$1.02M ﹤0.01% 2622
2020
Q1
$1.29M Sell
15,600
-37,200
-70% -$3.32M 0.01% 1127
2019
Q4
$5M Buy
52,800
+35,500
+205% +$3.19M 0.03% 577
2019
Q3
$1.5M Buy
17,300
+14,600
+541% +$1.31M 0.01% 1287
2019
Q2
$247K Sell
2,700
-12,924
-83% -$1.09M ﹤0.01% 2779
2019
Q1
$1.35M Sell
15,624
-13,838
-47% -$1.11M 0.01% 1400
2018
Q4
$2.27M Buy
29,462
+8,146
+38% +$634K 0.02% 982
2018
Q3
$1.65M Buy
21,316
+16,517
+344% +$1.22M 0.01% 1541
2018
Q2
$325K Buy
4,799
+1,451
+43% +$100K ﹤0.01% 3228
2018
Q1
$243K Sell
3,348
-4,910
-59% -$374K ﹤0.01% 3329
2017
Q4
$621 Sell
8,258
-61,604
-88% -$4.65M ﹤0.01% 2401
2017
Q3
$5.38K Buy
69,862
+39,507
+130% +$2.98M 0.03% 621
2017
Q2
$2.27K Sell
30,355
-27,900
-48% -$1.98M 0.01% 1107
2017
Q1
$3.88K Buy
58,255
+27,342
+88% +$1.82M 0.03% 630
2016
Q4
$2.02M Buy
30,913
+13,950
+82% +$905K 0.01% 951
2016
Q3
$1.2M Sell
16,963
-335
-2% -$24.4K 0.01% 1384
2016
Q2
$1.28M Sell
17,298
-8,482
-33% -$586K 0.01% 1375
2016
Q1
$1.67M Buy
25,780
+19,865
+336% +$1.35M 0.01% 980
2015
Q4
$456K Buy
5,915
+3,125
+112% +$248K ﹤0.01% 1954
2015
Q3
$230K Sell
2,790
-1,004
-26% -$89.4K ﹤0.01% 2243
2015
Q2
$336K Sell
3,794
-10,268
-73% -$942K ﹤0.01% 2027
2015
Q1
$1.25M Buy
14,062
+11,384
+425% +$1.01M 0.01% 890
2014
Q4
$222K Sell
2,678
-3,125
-54% -$259K ﹤0.01% 2217
2014
Q3
$489K Buy
5,803
+1,451
+33% +$117K 0.01% 1341
2014
Q2
$353 Sell
4,352
-447
-9% -$35.2K ﹤0.01% 1542
2014
Q1
$367 Sell
4,799
-3,794
-44% -$276K 0.01% 1496
2013
Q4
$618K Buy
8,593
+5,133
+148% +$357K 0.01% 1428
2013
Q3
$237K Sell
3,460
-223
-6% -$14.8K ﹤0.01% 1610
2013
Q2
$233K Buy
+3,683
New +$240K ﹤0.01% 1644

Other funds holding NVS

Walleye Trading's NVS Position: Q1 2026 in Review

Walleye Trading opened a new position in Novartis (NVS) in Q1 2026: 839 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #3342 among its holdings. This is a return to the name: Walleye Trading previously reported a position in NVS as recently as Q3 2025.

Walleye Trading first reported a position in NVS in Q1 2015 and has held it in 21 quarters since. The position peaked at $4.83M in Q3 2023. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Walleye Trading held 839 shares of Novartis worth $128K as of Q1 2026.
  • Novartis was a new Walleye Trading position in Q1 2026.
  • Novartis made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3342 holding.
  • Walleye Trading first reported a position in Novartis in Q1 2015 and has held it in 21 quarters since.
  • Walleye Trading's Novartis position peaked at $4.83M in Q3 2023.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.